ATE114970T1 - Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption. - Google Patents

Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption.

Info

Publication number
ATE114970T1
ATE114970T1 AT90907923T AT90907923T ATE114970T1 AT E114970 T1 ATE114970 T1 AT E114970T1 AT 90907923 T AT90907923 T AT 90907923T AT 90907923 T AT90907923 T AT 90907923T AT E114970 T1 ATE114970 T1 AT E114970T1
Authority
AT
Austria
Prior art keywords
cholesterol
absorbable
esterase inhibitors
reduce
absorption
Prior art date
Application number
AT90907923T
Other languages
English (en)
Inventor
Louis George Lange Iii
Curtis A Spilburg
Original Assignee
Louis George Lange Iii
Curtis A Spilburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/340,868 external-priority patent/US5017565A/en
Application filed by Louis George Lange Iii, Curtis A Spilburg filed Critical Louis George Lange Iii
Application granted granted Critical
Publication of ATE114970T1 publication Critical patent/ATE114970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90907923T 1989-04-20 1990-04-20 Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption. ATE114970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/340,868 US5017565A (en) 1989-04-20 1989-04-20 Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US07/429,398 US5063210A (en) 1989-04-20 1989-10-31 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption

Publications (1)

Publication Number Publication Date
ATE114970T1 true ATE114970T1 (de) 1994-12-15

Family

ID=26992276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90907923T ATE114970T1 (de) 1989-04-20 1990-04-20 Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption.

Country Status (10)

Country Link
US (1) US5063210A (de)
EP (1) EP0469079B1 (de)
JP (1) JPH0819001B2 (de)
AT (1) ATE114970T1 (de)
AU (1) AU633569B2 (de)
CA (1) CA2053258C (de)
DE (1) DE69014870T2 (de)
DK (1) DK0469079T3 (de)
ES (1) ES2064736T3 (de)
WO (1) WO1990012579A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008456A1 (en) * 1988-03-15 1989-09-21 The Jewish Hospital Of St. Louis Inhibition of intestinal cholesterol and fatty acid absorption
US5519010A (en) * 1989-02-06 1996-05-21 Taiho Pharmaceutical Co., Ltd. Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
DE4011285A1 (de) * 1990-04-06 1991-10-10 Steigerwald Arzneimittelwerk Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose
US5616570A (en) * 1991-10-18 1997-04-01 Lange, Iii; Louis G. Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
WO1995003058A1 (en) * 1993-07-21 1995-02-02 Belorussky Nauchno-Issledovatelsky Institut Kardiologii Oxidized starch derivatives as anti-aggregation, anticoagulant and anti-arrhythmic agents
WO1995017450A1 (de) * 1993-12-23 1995-06-29 Vianova Resins Aktiengesellschaft Verfahren zur herstellung von wasserverdünnbaren lackbindemitteln auf der basis von acrylatcopolymerisaten und deren verwendung
JPH09511753A (ja) * 1994-09-20 1997-11-25 ファイザー・インコーポレーテッド コレステロール吸収阻害薬とコレステロール合成阻害薬の併用
AU682792B2 (en) * 1994-10-13 1997-10-16 Cv Therapeutics, Inc. Method of manufacturing non-absorbable synthetic sulfated polysaccharides
US7071174B1 (en) 1994-10-13 2006-07-04 Cv Therapeutics, Inc. Method and composition for inhibiting cholesterol esterase
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
JPH11349485A (ja) * 1998-06-09 1999-12-21 Shirako Co Ltd 肝臓障害改善剤
PT1105123E (pt) * 1998-08-14 2004-08-31 Hoffmann La Roche Composicoes farmaceuticas contendo inibidores da lipase e quitosano
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
JP2003511388A (ja) * 1999-10-02 2003-03-25 アメリカ合衆国 繊維芽細胞増殖因子−５（ｆｇｆ−５）は腫瘍関連ｔ細胞抗原である
JP4601100B2 (ja) * 1999-11-08 2010-12-22 三生医薬株式会社 マスティックの油液を内包した軟カプセル
NZ523684A (en) * 2000-07-28 2005-04-29 F New pharmaceutical composition
EP1307263B1 (de) * 2000-07-28 2005-04-20 F. Hoffmann-La Roche Ag Neue verwendung von lipase-inhibitoren
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6949261B2 (en) 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis
US6946151B2 (en) * 2002-11-12 2005-09-20 Ayurvedic-Life International, Llc Therapeutic compositions
ES2251289B1 (es) 2004-02-27 2007-07-01 Bioiberica, S.A. Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
JPWO2008069276A1 (ja) * 2006-12-06 2010-03-25 株式会社カネカ 癌治療剤および発癌抑制剤
DE102007035322B4 (de) * 2007-07-25 2011-11-17 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate
US20100324075A1 (en) * 2007-12-21 2010-12-23 University Of Cincinnati Therapeutic use of carboxyl ester lipase inhibitors
US8022347B2 (en) * 2008-06-23 2011-09-20 Ricoh Company, Ltd. Optical scanning device, image forming apparatus, and optical scanning method having a plurality of light intensity control devices with a switching unit
GB0920633D0 (en) 2009-11-25 2010-01-13 Rdbiomed Ltd Inhibition of pancreatic lipase
EP2844303B1 (de) 2012-05-03 2021-09-15 Beth Israel Deaconess Medical Center, Inc. Lipide zur erhöhung der insulinempfindlichkeit und verfahren zur verwendung davon
EP2972399B1 (de) 2013-03-15 2020-09-02 Beth Israel Deaconess Medical Center, Inc. Lipide zur erhöhung der insulinempfindlichkeit und verfahren zur verwendung davon

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB871590A (en) * 1958-08-18 1961-06-28 Riker Laboratories Inc Water soluble antilipemic salts of sulphated polysaccharides
GB896876A (en) * 1958-08-18 1962-05-23 Riker Laboratories Inc Orally administrable hormonal and anti-coagulant medicines comprising chelating agents
US3148114A (en) * 1959-11-20 1964-09-08 American Cyanamid Co Method of reducing cholesterol levels
GB953626A (en) * 1961-04-25 1964-03-25 Meito Sangyo Kk Enteric-coated tablets of dextran sulphate ester and method of preparation thereof
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
GB1053143A (de) * 1963-03-29 1900-01-01
US3511910A (en) * 1966-04-08 1970-05-12 Frank E Halleck Animal food products for reducing plasma cholesterol levels
ES343957A1 (es) * 1967-08-09 1968-10-01 Rocador Sa Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
US3637657A (en) * 1968-04-01 1972-01-25 Meito Sangyo Kk Aluminum complex of sulfated polysaccharide and process for the preparation thereof
US3627872A (en) * 1968-04-08 1971-12-14 Upjohn Co Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides
DE2037942C2 (de) * 1970-04-15 1982-11-18 Biomed Research, Inc., 90048 Los Angeles, Calif. Arzneimittel enthaltend ein "aktives" Chondroitinsulfat als Wirkstoff zur Verhinderung des Auftretens atherosklerotischer Läsionen und zur Verhinderung des Auftretens von Herzanfällen
FR2192813B1 (de) * 1972-07-20 1975-08-08 Centre Etd Ind Pharma
JPS5027884A (de) * 1973-07-12 1975-03-22
IT1052819B (it) * 1975-12-12 1981-07-20 Fargal Pharmasint Lab Biochim Preparato inibitore dell assorbimento dei lipidi a base di dietilamminoetildestrano
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
US4066829A (en) * 1976-07-12 1978-01-03 American Cyanamid Company Malto-dextrin poly(H-)sulfates
JPS5515435A (en) * 1978-07-20 1980-02-02 Seikagaku Kogyo Co Ltd Blood platelet coagulation suppressing agent
US4220017A (en) * 1978-08-07 1980-09-02 Harold Freeman Jewelry Mfg. Co., Inc. Convertible finger ring
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US4411911A (en) * 1980-01-31 1983-10-25 Taiho Pharmaceutical Company, Limited Method of treating hyperlipidemia and inflammation with sulfonate derivatives
IT1140999B (it) * 1980-06-18 1986-10-10 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante
JPS5790002A (en) * 1980-11-27 1982-06-04 Asahi Chem Ind Co Ltd Cellulose sulfate containing heparin-like property and its production
IT1144697B (it) * 1981-04-06 1986-10-29 Texcontor Ets Derivato semi-sintetico della chitina processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
FR2555993B1 (fr) * 1983-12-06 1986-11-07 Anic Spa Chitosanes 6-sulfates et procede pour leur preparation
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
US4520017A (en) * 1983-02-04 1985-05-28 Tunc Deger C Method of reducing nutrient absorption
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
FR2574663B1 (fr) * 1984-12-17 1987-01-16 Sanofi Sa Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
DE3634392A1 (de) * 1986-10-09 1988-04-14 Knoll Ag Verwendung polysulfatierter niedermolekularer dextransulfate
DE3705669A1 (de) * 1987-02-21 1988-09-01 Thomae Gmbh Dr K Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen

Also Published As

Publication number Publication date
DE69014870T2 (de) 1995-04-27
EP0469079A1 (de) 1992-02-05
DE69014870D1 (de) 1995-01-19
ES2064736T3 (es) 1995-02-01
WO1990012579A1 (en) 1990-11-01
DK0469079T3 (da) 1995-07-10
US5063210A (en) 1991-11-05
JPH04503813A (ja) 1992-07-09
JPH0819001B2 (ja) 1996-02-28
AU633569B2 (en) 1993-02-04
CA2053258A1 (en) 1990-10-21
CA2053258C (en) 1998-02-10
AU5535690A (en) 1990-11-16
EP0469079B1 (de) 1994-12-07

Similar Documents

Publication Publication Date Title
ATE114970T1 (de) Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption.
DK0513709T4 (da) Enzymatisk fremgangsmåde til formindskelse af indholdet af phosphorholdige bestanddele i vegetabilske og animalske olier
EA200601059A1 (ru) Сложные моноэфиры пробукола для лечения сердечно-сосудистых и воспалительных заболеваний
BR9407752A (pt) Preparaçao de enzima aditivo detergente composiçao detergente processo para o tratamento de fibras lignocelulósicas
DK76889D0 (da) Fremgangsmaade til fremstilling af organiske forbindelser
DK0542864T3 (da) Anvendelse af phospholipider til fremstilling af et topisk lægemiddel til modifikation af serumcholesterolniveauer
FI94265C (fi) Menetelmä lignoselluloosamateriaalin valkaisemiseksi happi- ja entsyymikäsittelyllä
ES2087976T3 (es) Fibra de poliolefina hidrofoba cardable, material y procedimiento para su preparacion.
DK0785948T3 (da) Analoger af keratinocyt vækstfaktor
DE69007223D1 (de) Verfahren und zusammensetzung von geprägten schuhsohlen.
MY114765A (en) Preparation for epidermis
FI932558A0 (fi) Menetelmä liukoisen ravintokuidun rikastamiseksi
DE69001248D1 (de) Verfahren und zusammensetzungen zur isolation von menschlichem relaxin.
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
DE69712578D1 (de) Verwendung mindestens eines in 6-Stellung substituierten Pyrimidin-3-oxids zur Stimulierung von Tyrosinase
DK0487557T3 (da) Forbedring af pulpblegning
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE3853656D1 (de) Verfahren zur Umesterung von Ölen und Fetten in Anwesenheit einer Fettsäure, eines Fettsäureesters oder eines anderen Öls oder Fettes mittels einer alkalischen hoch-molekularen Lipase.
ATE61051T1 (de) Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase.
ATE113072T1 (de) Verfahren zur konservierung pflanzlicher embryonen.
FI905005A7 (fi) Tyydytettyjä C20-24-rasvahappoja sisältäviä triglyseridejä, jotka ovatkäyttökelpoisia alentamaan veren kolesterolipitoisuutta
FI914132A7 (fi) Menetelmä pienen rasvapitoisuuden omaavien koostumusten uuttamiseksi biologista alkuperää olevista aineista
UA37199C2 (uk) Алкіламінокетони
FI905558A7 (fi) Menetelmä kolesteroliesterihydrolaasi-inhibiittoreiden valmistamiseksi
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time